Reviva pharmaceuticals to present at the 35th annual roth conference

Cupertino, calif., march 07, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will present at the 35th annual roth conference, taking place march 12-14 in dana point, ca. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking